ELI LILLY & Co is 9.7x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($1.072 T vs $110.46 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRTX | LLY |
|---|---|---|
| Market cap | $110.46 B | $1.072 T |
| US-listed rank | #136 | #10 |
| Revenue (latest FY) | $12.00B | $65.18B |
| Net income (latest FY) | $3.95B | $20.64B |
| Net margin | 32.9% | 31.7% |
| P/E (trailing FY) | 27.9 | 51.9 |
| SEC filings | 1,000 | 989 |
ELI LILLY & Co is 9.7x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($1.072 T vs $110.46 B).
In their latest fiscal years, VERTEX PHARMACEUTICALS INC / MA reported $12.00B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: VERTEX PHARMACEUTICALS INC / MA and ELI LILLY & Co, or browse the full rankings.